Table 1 Association of LCN2 expression with the features of OSCC patients
Clinical characteristics | LCN2 expression | P value | |
|---|---|---|---|
High expression(%) | Low expression(%) | ||
Age | |||
  ≤ 40 | 13(39.39) | 20(60.61) | 0.7135 |
 40–50 | 10(47.62) | 11(52.38) | |
 50–60 | 11(45.83) | 13(54.17) | |
  > 60 | 16(34.78) | 30(65.22) | |
Gender | |||
 Male | 32 (41.56) | 45(58.44) | 0.7195 |
 Female | 18 (38.30) | 29(61.70) | |
Differentiation | |||
 High | 17 (29.31) | 41(70.69) | 0.0179 |
 Mieddle | 19 (43.18) | 25(56.82) | |
 Low | 14 (63.64) | 8(36.36) | |
Lymphatic metastasis | |||
 No | 19 (29.23) | 46(70.77) | 0.008 |
 Yes | 31 (52.54) | 28(47.46) | |
Clinical T stages | |||
 1 | 6 (20.00) | 24(80) | 0.015 |
 2 | 13 (35.14) | 24(64.86) | |
 3 | 15 (51.72) | 14(48.28) | |
 4 | 16(57.14) | 12(42.86) | |